CHINNAMPALLI, K. V. FROM RISK TO QUALITY: QUALITY RISK MANAGEMENT IN PHARMA TARGETING CANCER THROUGH IMMUNE MODULATION . Biospecia, [S. l.], v. 2, n. 2, p. 13–17, 2026. Disponível em: https://uniquepubinternational.com/journals/index.php/biospecia/article/view/211. Acesso em: 29 jul. 2026.